CUBT on OTC

Curative Biotechnology Inc

Curative Biotechnology Inc is an American biological products company based in Boca Raton, listed on OTC (CUBT).1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with another stock.

  • TickerCUBT on OTC1
  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersBoca Raton, Florida1
  • Incorporated inFL2
  • Business address1825 Nw Corporate Blvd, Suite 110, Boca Raton, Fl 334312
  • Legal formCorporation

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Chief Strategy OfficerBarry A. Ginsberg named Mar 21, 2022 to Jan 18, 20233
  • Executive OfficerI Richard Garr named Jan 18, 20233
  • President & Chairman of the Board of DirectorsPaul Richard Michaels named Jan 18, 20233
  • Executive OfficerGarr Richard named Mar 21, 20224
  • Executive Officer, DirectorPaul Michaels named Mar 21, 20224
  • DirectorCary A. Sucoff named Jan 18, 20233
  • DirectorLawrence A. Zaslow named Jan 18, 20233
  • DirectorMichael Richard Fish named Jan 18, 20233
  • DirectorMichael Fish named Mar 21, 20224

Former names

  • Connectyx Technologies CorpMay 9, 2007 to Oct 13, 20092

Filings

47 filings to the SEC since October 2021: 2 private raises, 45 other. The latest 20:

  1. Dec 22, 2025RW EDGAR
  2. Aug 1, 2025S-1/A EDGAR
  3. May 6, 2024S-1 EDGAR
  4. Feb 1, 2024RW EDGAR
  5. Jan 25, 2023S-1/A EDGAR
  6. Jan 18, 2023D EDGAR
  7. Jan 13, 2023S-1/A EDGAR
  8. Jan 9, 2023S-1/A EDGAR
  9. Dec 1, 20228-A12B/A EDGAR
  10. Nov 30, 2022S-1/A EDGAR
  11. Nov 16, 2022S-1/A EDGAR
  12. Nov 7, 2022S-1 EDGAR
  13. Oct 31, 2022RW EDGAR
  14. Oct 13, 2022EFFECT EDGAR
  15. Oct 11, 2022CORRESP EDGAR
  16. Oct 5, 20228-A12B EDGAR
  17. Oct 5, 2022CERT NYSE AMERICAN CERTIFICATION EDGAR
  18. Sep 30, 2022CORRESP EDGAR
  19. Sep 30, 2022S-1/A EDGAR
  20. Sep 29, 2022UPLOAD EDGAR

The 47 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Dec 15, 2022Raised $146,000 in a private offering of equity Form D: $919,000 offered in all Form D
  2. Mar 4, 2022Raised $1 million in a private offering of debt Form D: 1 investor so far Form D

SEC filer profile

How Curative Biotechnology Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCurative Biotechnology Inc1
  • CIK0001400271
  • Employer ID (EIN)72-15506581
  • Incorporated inFlorida1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1825 Nw Corporate Blvd, Suite 110, Boca Raton, FL 334311
  • Phone800-526-80061
  • On EDGAR sinceMay 9, 20071
  • Filings51 in all: S-1/A (15), UPLOAD (8), CORRESP (7), D (3), RW (3), S-1 (3), DRS/A (2), DRSLTR (2)1
    All 16 form types

    8-A12B (1), 8-A12B/A (1), 8-K12B (1), CERT (1), DRS (1), EFFECT (1), REGDEX (1), REGDEX/A (1)